carbapenems has been researched along with panipenem in 36 studies
Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (panipenem) | Trials (panipenem) | Recent Studies (post-2010) (panipenem) |
---|---|---|---|---|---|
7,355 | 147 | 5,277 | 96 | 5 | 9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 17 (47.22) | 18.2507 |
2000's | 17 (47.22) | 29.6817 |
2010's | 2 (5.56) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gotoh, N; Nishino, T | 1 |
Mitsuhashi, S; Yoshida, M | 1 |
Kawahara, Y; Shimada, J | 1 |
Hirouchi, Y; Hori, R; Inui, K; Kamiya, A; Kawahara, Y; Naganuma, H; Okada, R | 1 |
Hashizume, T; Hazumi, N; Kato, Y; Matsuda, K | 1 |
Kanazawa, K; Nouda, H; Sunagawa, M | 1 |
Domon, H; Fukuoka, T; Hirasawa, A; Ishii, C; Kakuta, M; Ohya, S; Utsui, Y; Yasuda, H | 1 |
Hirata, Y; Igari, J; Imafuku, Y; Inoue, M; Ishigo, S; Kawaguchi, R; Kobayashi, I; Kumasaka, K; Matsuoka, K; Murakami, E; Nishino, T; Oguri, T; Ohtaki, Y; Okada, J; Okamoto, E; Saeki, H; Satou, S; Shibano, T; Takahashi, A; Tokuda, K; Uchida, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H | 1 |
Kimpara, I; Kudo, E; Kudo, H; Kudo, Y; Miura, T; Saitoh, Y; Sato, S; Tsujino, M | 2 |
Kinoshita, S; Kumagai, S | 1 |
Horii, T; Ichiyama, S; Kobayashi, M; Ohta, M | 1 |
Hirata, Y; Hongo, T; Igari, J; Imafuku, Y; Inoue, M; Kawaguchi, R; Kobayashi, I; Kobayasi, Y; Kumasaka, K; Matsumoto, N; Nakasaki, N; Nishino, T; Oguri, T; Ohtaki, Y; Okada, J; Saeki, H; Sasaki, T; Satou, S; Shibano, T; Takahashi, A; Tokuda, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H | 1 |
Igari, J | 1 |
Arita, K; Daido, K; Kohara, T; Nakamura, K; Ohashi, N; Takeshima, Y | 1 |
Fujimura, S; Gomi, K; Honda, Y; Kikuchi, T; Kobayashi, T; Nukiwa, T; Shoji, S; Takahashi, H; Tokue, Y; Watanabe, A; Yasui, S | 1 |
Deguchi, K; Endo, H; Ishihara, R; Matsumoto, Y; Nishinari, C; Suzuki, Y | 1 |
Aoki, N; Hashimoto, T; Hirata, Y; Hongo, T; Igari, J; Imafuku, Y; Inoue, M; Ishigo, S; Kajimura, K; Kawaguchi, R; Kobayashi, I; Kobayashi, Y; Kumasaka, K; Matsumoto, N; Matsuoka, K; Murakami, E; Nakasaki, N; Nishino, T; Oguri, T; Ohba, Y; Ohtaki, Y; Okada, J; Okamoto, E; Ono, J; Saeki, H; Sasaki, T; Satou, S; Shibano, T; Takahashi, A; Takata, T; Tokuda, K; Uehara, N; Watanabe, N; Yomoda, S; Yoshida, H | 1 |
Imura-Miyoshi, K; Naganuma, H; Yamamura, N | 1 |
Endo, H; Jinbo, K; Nishinari, C; Suzuki, Y; Tamura, C | 1 |
Asano, N; Hara, Y; Hu, ZQ; Shimamura, T; Yoda, Y; Zhao, WH | 1 |
Hikida, M; Inoue, M; Okamoato, R; Sato, Y; Terashima, S | 1 |
Chinzei, T; Ishida, A; Tasaka, K | 1 |
Abe, T; Fukuoka, T; Inoue, M; Ishii, C; Kakuta, M | 1 |
Abe, T; Fukuoka, T; Ito, K; Sato, Y; Sei, M | 1 |
Hashimoto, H; Horii, T; Kanno, T; Maekawa, M; Morita, M; Muramatsu, H | 1 |
Hashimoto, K; Ito, K; Ogata, H | 1 |
Kiribayashi, Y; Maeda, Y; Murakami, T; Nagai, J; Omoda, K; Takano, M; Yumoto, R | 1 |
Abe, K; Arai, T; Hasebe, N; Horiuchi, M; Kimura, M; Tokumura, M | 1 |
Sakata, H | 1 |
Joo, JY; Kim, JH; Kwon, OH; Lee, SG | 1 |
Shah, PM | 1 |
Hori, S; Kizu, J; Kurihara, Y | 1 |
Goto, T; Ichiishi, T; Mikamo, H; Nakao, K; Tanaka, K; Watanabe, K; Yamagishi, Y | 1 |
Hino, M; Kanamaru, A; Masaoka, T; Nakagawa, Y; Ohta, K; Ohyashiki, K; Suzuki, K; Tamura, K; Urabe, A | 1 |
Fisher, S; Galanis, C; Gupta, C; Kaushik, A; Lamichhane, G; Parrish, N; Story-Roller, E | 1 |
1 review(s) available for carbapenems and panipenem
Article | Year |
---|---|
Parenteral carbapenems.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; beta-Lactams; Carbapenems; Ertapenem; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Humans; Imipenem; Infusions, Parenteral; Meropenem; Thienamycins | 2008 |
2 trial(s) available for carbapenems and panipenem
Article | Year |
---|---|
Overview of a new carbapenem, panipenem/betamipron.
Topics: Alanine; Animals; Carbapenems; Dogs; Half-Life; Humans; In Vitro Techniques; Kidney; Macaca fascicularis; Rats; Rats, Wistar; Species Specificity; Thienamycins | 1994 |
Prospective randomized study of cefepime, panipenem, or meropenem monotherapy for patients with hematological disorders and febrile neutropenia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Carbapenems; Cefepime; Cephalosporins; Female; Fever; Hematologic Diseases; Humans; Male; Meropenem; Neutropenia; Prospective Studies; Thienamycins; Treatment Outcome; Young Adult | 2013 |
33 other study(ies) available for carbapenems and panipenem
Article | Year |
---|---|
Decreases of the susceptibility to low molecular weight beta-lactam antibiotics in imipenem-resistant Pseudomonas aeruginosa mutants: role of outer membrane protein D2 in their diffusion.
Topics: Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; beta-Lactams; Carbapenems; Diffusion; Drug Resistance, Microbial; Electrophoresis, Polyacrylamide Gel; Imipenem; Lactams; Liposomes; Microbial Sensitivity Tests; Molecular Weight; Permeability; Pseudomonas aeruginosa; Thienamycins | 1990 |
In vitro antibacterial activity and beta-lactamase stability of the new carbapenem LJC10,627.
Topics: Bacteria; beta-Lactamases; Carbapenems; Cefpirome; Ceftazidime; Cephalosporins; Humans; Imipenem; Molecular Structure; Thienamycins | 1990 |
Preventive effect of betamipron on nephrotoxicity and uptake of carbapenems in rabbit renal cortex.
Topics: Alanine; Animals; Carbapenems; Glycosuria, Renal; Imipenem; In Vitro Techniques; Kidney Cortex; Kidney Diseases; Male; Necrosis; Proteinuria; Rabbits; Thienamycins | 1994 |
Effects of a beta-lactamase inhibitor, sulbactam, on the activity of carbapenems against Pseudomonas aeruginosa.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Carbapenems; Drug Synergism; Enzyme Inhibitors; Imipenem; Meropenem; Pseudomonas aeruginosa; Sulbactam; Thienamycins | 1995 |
Structure-activity relationships of carbapenem compounds to anti-Haemophilus influenzae activity and affinity for penicillin-binding proteins. Effect of 1 beta-methyl group and C-2 side chain.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Carbapenems; Carrier Proteins; Haemophilus influenzae; Hexosyltransferases; Imipenem; Meropenem; Methylation; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Protein Binding; Structure-Activity Relationship; Thienamycins | 1997 |
[Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus].
Topics: Animals; Anti-Bacterial Agents; Bacterial Proteins; Burns; Carbapenems; Carrier Proteins; Drug Resistance, Microbial; Drug Synergism; Hexosyltransferases; Methicillin Resistance; Mice; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Pseudomonas Infections; Staphylococcal Infections; Staphylococcus aureus; Thienamycins; Vancomycin | 1997 |
[Survey of sensitivities of clinical isolates to antibacterial agents (annual report)].
Topics: 4-Quinolones; Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Cocci; Haemophilus influenzae; Humans; Imipenem; Meropenem; Monobactams; Penicillins; Pseudomonas aeruginosa; Serratia marcescens; Thienamycins | 1997 |
[In vitro combination effect of vancomycin and carbapenems against carbapenem-resistant MRSA].
Topics: Anti-Bacterial Agents; Carbapenems; Imipenem; Meropenem; Methicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1997 |
[In vitro antibacterial activity of vancomycin in combination with panipenem against carbapenem-resistant MRSA].
Topics: Carbapenems; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Hydrogen-Ion Concentration; Methicillin Resistance; Staphylococcus aureus; Thienamycins; Vancomycin | 1998 |
[Antimicrobial activity of carbapenem antibiotics against gram-negative bacilli].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aztreonam; Carbapenems; Cefozopran; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Gram-Negative Bacteria; Humans; Imipenem; Meropenem; Monobactams; Norfloxacin; Tetracycline; Thienamycins | 1998 |
Relationship between morphological changes and endotoxin release induced by carbapenems in Pseudomonas aeruginosa.
Topics: Carbapenems; Endotoxins; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins | 1999 |
[Survey of the sensitivities of clinical isolates to antibacterial agents (annual report)].
Topics: Carbapenems; Drug Resistance, Microbial; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Thienamycins; Time Factors | 1999 |
[In vitro antimicrobial activity of carbapenem antibiotics against Pseudomonas aeruginosa, measured using a low-concentration Mueller-Hinton Agar culture medium].
Topics: Agar; Carbapenems; Culture Media; Dose-Response Relationship, Drug; Drug Interactions; Drug Resistance, Microbial; Pseudomonas aeruginosa; Thienamycins | 1999 |
[Study on antibiotics susceptibility and mechanism of carbapenem-resistance in clinical isolates of Pseudomonas aeruginosa].
Topics: Anti-Infective Agents; beta-Lactam Resistance; Carbapenems; Ceftazidime; Cephalosporins; Imipenem; Meropenem; Ofloxacin; Pseudomonas aeruginosa; Thienamycins | 1999 |
[In vitro activity of biapenem (BIPM) against clinically isolated respiratory pathogens in 1996-1998].
Topics: Bacteria; Carbapenems; Ceftazidime; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Penicillins; Piperacillin; Respiratory Tract Infections; Thienamycins; Time Factors | 1999 |
[Antimicrobial activities of meropenem against clinically isolated strains in 1997].
Topics: Bacteria; Carbapenems; Cephalosporins; Drug Resistance, Microbial; Humans; Imipenem; Meropenem; Thienamycins; Time Factors | 1999 |
[Changes in the antibacterial activity of chemotherapeutic agents (especially carbapenems) for 10 species of clinical isolates between 1994 and 1996. Surveillance group of the sensitivities of clinical isolates to antibacterial agents].
Topics: Bacteria; Carbapenems; Drug Resistance, Microbial; Humans; Imipenem; Japan; Meropenem; Multicenter Studies as Topic; Thienamycins; Time Factors | 2000 |
Panipenum, a carbapenem antibiotic, increases the level of hepatic UDP-glucuronic acid in rats.
Topics: Animals; Carbapenems; In Vitro Techniques; Liver; Male; Microsomes, Liver; Rats; Rats, Sprague-Dawley; Thienamycins; Uridine Diphosphate Glucuronic Acid; Valproic Acid | 2000 |
[Antimicrobial activities of carbapenems and fourth generation cephems against clinically isolated strains].
Topics: Bacteria; Carbapenems; Cefepime; Cefozopran; Cephalosporins; Imipenem; Meropenem; Thienamycins | 2001 |
Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin-resistant Staphylococcus aureus.
Topics: Antioxidants; Carbapenems; Catechin; Colony-Forming Units Assay; Drug Synergism; Methicillin Resistance; Microbial Sensitivity Tests; Staphylococcus aureus; Thienamycins | 2002 |
[Comparative antibacterial activity of carbapenems against P. aeruginosa (1)].
Topics: beta-Lactamases; Carbapenems; Drug Resistance, Microbial; Imipenem; Meropenem; Pseudomonas aeruginosa; Thienamycins | 2001 |
[Antimicrobial activity of carbapenems and the combined effect with aminoglycoside against recent clinical isolates of Pseudomonas aeruginosa].
Topics: Amikacin; Anti-Bacterial Agents; Carbapenems; Drug Synergism; Drug Therapy, Combination; Imipenem; Meropenem; Pseudomonas aeruginosa; Thienamycins | 2002 |
[Rapid bactericidal activities of carbapenems against Pseudomonas aeruginosa in simulating human plasma concentrations].
Topics: Carbapenems; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microscopy, Electron, Scanning; Models, Biological; Pseudomonas aeruginosa; Thienamycins | 2002 |
[Antibacterial activity of panipenem against clinical isolates in 2000 and 2001].
Topics: Adolescent; Adult; Bacteria; Bacterial Infections; beta-Alanine; Carbapenems; Cephalosporins; Child; Dosage Forms; Drug Resistance, Bacterial; Humans; Japan; Microbial Sensitivity Tests; Product Surveillance, Postmarketing; Thienamycins; Time Factors | 2002 |
Effect of basic amino acids on susceptibility to carbapenems in clinical Pseudomonas aeruginosa isolates.
Topics: Amino Acids, Basic; Anti-Bacterial Agents; Aztreonam; Carbapenems; Ceftazidime; Culture Media; Humans; Hydrogen-Ion Concentration; Imipenem; Meropenem; Microbial Sensitivity Tests; Porins; Pseudomonas aeruginosa; Thienamycins | 2003 |
[Activity of cephems and carbapenems against clinically isolated Mycobacterium abscessus].
Topics: Carbapenems; Cefoxitin; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Humans; Imipenem; Meropenem; Microbial Sensitivity Tests; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Thienamycins; Tuberculosis, Pulmonary | 2003 |
Increased erythrocyte distribution of valproic acid in pharmacokinetic interaction with carbapenem antibiotics in rat and human.
Topics: Adult; Animals; Anticonvulsants; Area Under Curve; Carbapenems; Drug Interactions; Erythrocytes; Female; Humans; Imipenem; Male; Metabolic Clearance Rate; Rats; Rats, Wistar; Thienamycins; Time Factors; Valproic Acid | 2005 |
Absence of convulsive liability of doripenem, a new carbapenem antibiotic, in comparison with beta-lactam antibiotics.
Topics: Alanine; Animals; Anti-Bacterial Agents; Anticonvulsants; Carbapenems; Convulsants; Dogs; Doripenem; Drug Interactions; Electroencephalography; Injections, Intravenous; Injections, Intraventricular; Male; Meropenem; Mice; Mice, Inbred ICR; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Thienamycins; Valproic Acid | 2006 |
[Relationship between protein binding and antimicrobial activities of antibiotics against Streptococcus pneumoniae and Haemophilus influenzae].
Topics: Administration, Oral; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Child; Haemophilus influenzae; Humans; Injections, Intravenous; Meropenem; Microbial Sensitivity Tests; Protein Binding; Streptococcus pneumoniae; Thienamycins | 2006 |
[Seven cases of decreased serum valproic acid concentration during concomitant use of carbapenem antibiotics].
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anticonvulsants; Carbapenems; Drug Interactions; Drug Therapy, Combination; Epilepsy; Female; Humans; Imipenem; Male; Meropenem; Middle Aged; Thienamycins; Valproic Acid | 2007 |
Simple and rapid determination of serum carbapenem concentrations by high-performance liquid chromatography.
Topics: Animals; Anti-Bacterial Agents; Carbapenems; Chromatography, High Pressure Liquid; Imipenem; Male; Meropenem; Mice; Thienamycins | 2008 |
In vitro activity of tomopenem (CS-023/RO4908463) against anaerobic bacteria.
Topics: Anti-Bacterial Agents; Bacteria, Anaerobic; Carbapenems; Doripenem; Meropenem; Microbial Sensitivity Tests; Thienamycins | 2009 |
Combinations of avibactam and carbapenems exhibit enhanced potencies against drug-resistant Mycobacterium abscessus.
Topics: Azabicyclo Compounds; beta-Lactamase Inhibitors; beta-Lactams; Carbapenems; Drug Resistance, Multiple, Bacterial; Ertapenem; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Thienamycins | 2017 |